Escherichia coli mastitis in cattle being treated for Staphylococcus aureus intramammary infection.
Middleton
J R
JR
Department of Veterinary Medicine and Surgery, College of Veterinary Medicine, University of Missouri, Columbia, MO 65211, USA.
Luby
C D
CD
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002417:Cattle; D002981:Clindamycin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003002:Clonixin / Q000031:analogs & derivatives / Q000627:therapeutic use; D004926:Escherichia coli / Q000187:drug effects / Q000254:growth & development / Q000302:isolation & purification*; D004927:Escherichia coli Infections / Q000382:microbiology / Q000662:veterinary*; D005260:Female; D008414:Mastitis, Bovine / Q000188:drug therapy / Q000382:microbiology*; D008892:Milk / Q000166:cytology; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D012189:Retrospective Studies; D012307:Risk Factors; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology / Q000662:veterinary*
D000900:Anti-Bacterial Agents; D011448:Prostaglandin Antagonists; D002981:Clindamycin; C014558:flunixin meglumine; C034093:pirlimycin; D003002:Clonixin